Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)

A Multicenter, Double-Blind, Placebo Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral Montelukast Versus Placebo in Persistent Asthma Which is Also Active During Allergy Seasons in Pediatric Patients With Seasonal Aeroallergen Sensitivity

This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma which is also active during allergy seasons in pediatric patients with seasonal aeroallergen sensitivity.

Inclusion Criteria:

• Male and female patients, ages 6 to 14 years, with persistent asthma that is also active during allergy season
• Patients must demonstrate positive skin prick tests to seasonally relevant geographic aeroallergens

Exclusion Criteria:

• Patient cannot have any other acute or chronic pulmonary disorder